Many women feel they were unfairly robbed of their femininity and suffer from anxiety and lack of confidence in social situations, sometimes to the point where it impacts their ability to function optimally at work, thus negatively affecting them financially as well as emotionally and psychologically.Chemotherapy patients often harbor hopes that the end of their treatment cycles will usher in a new chapter of their lives as cancer survivors — a welcome ending or abatement of the stress and pain they suffered due to their cancer — so that they can move on with their lives with a renewed sense of vigor.But many Taxotere victims, even those whose chemotherapy was successful and ended long ago, feel that their hair loss permanently and publicly marks them as cancer patients. It's difficult to know if it was the Taxotere or the Femara, or (my guess) probably both. However, instead of a clear warning, U.S. package labels contained only vague information about possible hair loss, with the claim that it “generally regrows.”Taxotere is a synthetic version of a naturally occurring compound known as Administered intravenously, Taxol can cause inflammation and tissue damage if not carefully administered. Transplantation isn’t always successful, and besides, it’s not a viable approach for individuals who have lost all of their hair.Prevention of hair loss is a field that’s seen more success in recent years. French oncologist If you experienced permanent alopecia after completing Taxotere treatment, you may qualify for compensation. A number of studies have been performed on various types of cold caps and have demonstrated a modest level of success. For example, eyebrows, eyelashes, and body hair on the arms, legs and other common locations may take longer. One well-known, common side effect of chemotherapy is alopecia, or hair loss. The patient must have received Taxotere through an IV, taken the drug before December 2015 and suffered permanent hair loss.If you, or someone who you know, fits into that category, it is important to file a lawsuit.There is serious compensation to be gained from the manufacturer, Sanofi-Aventis.Every person is different. They have had many lawsuits. Yet, most also state their oncologists didn’t warn them about this potential risk. The decision to file, whether to accept a settlement, or to go to trial is entirely in your hands.It is very important to speak with an attorney immediately if you suffered the side effect of permanent alopecia after taking Taxotere as part of your treatment for cancer. The type of lawsuits being filed against the manufacturers of Taxotere are referred to as multidistrict litigation, or It will be up to an individual to determine what version of Taxotere they were given by doctors during their breast cancer treatment.The idea behind the Taxotere lawsuit being MDL is because all of the cases get transferred to one court and are heard in front of one judge. Based on the outcomes of these five cases, Sanofi-Aventis may choose to settle with the remaining plaintiffs or find itself fighting an ongoing legal battle that could continue for several years.It is worth noting that this is not the first time a major drug company has issued warnings about a product in Europe and Canada, but failed to do so in the U.S. However, based on conclusions from a U.K. study conducted in 2013, up to 15 percent of women who undergo treatment with Taxotere experience permanent hair loss. It also means that litigation can move quicker, and the individuals filing lawsuits can expect a similar settlement offer from the manufacturers for each case.If the cases were going in front of different courts in different states, the possible settlement offers would depend heavily on whether the manufacturer expected the judge to side in their favor or not.The drug was first green-lit in 1996, but the fact that permanent hair loss was a side effect was only mentioned on drug labels in December 2015. This is a scam. I came across this forum whilst researching Taxotere and permanent hair loss. Ohilly Some cases may only result in damages for medical bills, while the full slate of reasons may come into play for other patients. Get a free case review now (866) 683-9122. Although a preliminary discussion about a possible settlement got underway, no official statement has been released, yet. The dates have been set for May and September 2019, and May and September 2020. It’s important to remember that new hair regrowth will likely look quite different after chemotherapy ends. In most cases, this hair loss is temporary. Hair starts growing back in two to three months after the chemo is finished. 171 likes. These drugs are combined to give patients the best chance of beating their cancer diagnosis.The infusion cycles are typically one hour, and these infusions are delivered every three to four weeks.Taxotere is given to a patient through a vein, because there is no pill form of the drug. The information provided within this site is not a substitute for professional medical advice, diagnosis or treatment. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes. Taxotere may lead to Permanent Hair Loss. It signals the end of a traumatic time and instills hope at the opportunity to start life over again.

Anyone who was treated with Taxotere after December 2015 is NOT eligible to file.Eventually, in August 2018 another 353 cases have been consolidated in New Jersey Superior Court as a new multi-county litigation.

Copyright © 2018 | The Product Lawyers - Sponsored by Justice Guardians, LLC - Attorney Advertising (For example: Patients treated with brain radiation versus tamoxifen may experience radically different hair loss timing.) Several Taxotere lawsuits are now scheduled against the manufacturer in 2020.

Don’t hesitate to contact us and fill out the form you see when you scroll up this page.The only downside to filing is that it can take years to get a favorable settlement – but that makes it even more important to file quickly.One of the good things about bringing forward a lawsuit at this stage is the fact that the drug manufacturer is inclined to settle. I was told at the time of diagnosis I could try the cold cap but it wasn’t well tolerated and not always successful.